Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer Consumer Health True To Form Pending Move To JV With GSK

Executive Summary

Pfizer consumer health sales up 4% to $3.6bn in 2018 as it prepares to move business into JV with GSK anticipated to close in the second half of 2019. Following 2% growth in 2017, a flat year in 2016 and a dip in 2015, Pfizer's view is confirmed of consumer health as a reliable revenue stream but not a strong growth driver.

Advertisement

Related Content

Q4 Consumer Health Earnings Preview: GSK, Bayer, RB, And Sanofi
GSK And Pfizer Start Consumer JV For Different Reasons, Aim For Similar Goals
Pfizer elevates Bourla as Read steps down
With Its Own Home, Pfizer Consumer Health Gets Higher Profile For Sale
Pfizer Mum On Consumer Business Plans As Analysts Say Spin-off
Pfizer Mum On Consumer Business Plans As Analysts Say Spin-off
Consumer Business An Asset To Pfizer, A Divestment Chip To Analysts
Consumer Business An Asset To Pfizer, A Divestment Chip To Analysts
Industry Roundup: Pfizer Earnings, Tylenol Litigation, FTC Enforcement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS124673

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel